August 1991. Both a circular tumor in the lower esophagus and an irregular elevated lesion in the gastric cardia were discovered by upper gastrointestinal endoscopy. Later, a diagnosis of moderately differentiated adenocarcinoma was made by biopsy. The patient was referred to our hospital in September 1991 for further examination of the lower esophageal tumor. He was not taking any medication and had no history of smoking or excessive alcohol consumption. There were no abnormal abdominal findings; however, there was mild anemia in the palpebral conjunctiva.
Introduction
A true collision carcinoma at the esophagogastric junction is rare. In this article, we report a case of double primary cancers of the esophagus and the stomach and discuss these cancers.
Case report
A 68-year-old man with no history of gastric complaints reported to a neighboring clinic with dysphagia in Gross examination of the resected specimen revealed ulcerated carcinoma, measuring 5 ϫ 5.5 ϫ 2.5 cm, without a capsule, in the gastric cardia and lower esophagus (Fig. 3) .
Pathological analysis of the esophageal tumor revealed well differentiated squamous cell carcinoma with cornification invading the muscular layer but not the diaphragm and pleura. The gastric tumor was a moderately differentiated adenocarcinoma invading the subserosa. The areas of squamous differentiation were on the esophageal side of the tumor with an epithelial lesion, and were adjacent to normal mucosa. The areas of glandular differentiation were to the gastric side of tumor, with an epithelial lesion, and were adjacent to normal mucosa. These two tumors collided at the esophagocardiac junction, but there was no intermingling (Figs 4, 5 ). There were tumor emboli in the lymphatics and blood vessels. In one left cardial lymph node, metastatic adenocarcinoma without any squa- There is no histological transition zone. H&E ϫ 400 mous component was discovered. In another cardial lymph node, independent non-intermingled metastatic adenocarcinoma and squamous cell carcinoma were observed. A supradiaphragmatic lymph node showed metastatic squamous cell carcinoma.
The patient's immediate postoperative course was uneventful, but he died of peritoneal recurrence of squamous cell carcinoma, in October 1992. An autopsy was not performed, so a detailed pathological report was not possible.
Discussion
The present case was diagnosed, on the basis of histological evidence, as a collision carcinoma at the esophagogastric junction. The occurrence of colliding esophageal squamous cell carcinoma and gastric adenocarcinoma at the esophagogastric junction is rare. We found seven previous reports of esophagogastric collision tumor in the literature [1] [2] [3] [4] [5] [6] [7] .
It was noted that combined carcinomas generated from two different histological types of tumors were classified into three groups. Meyer [8] defines a collision tumor as the colliding of histologically different tumors from independent primary sites. Wanke [1] and Spagnolo and Heenan [3] insist on the presence of a zone of intermingling or gradual transition. Dodge's [9] criteria include partial topographical separation and little or no evidence of an intermediate histological structure.
In our patient, areas of squamous differentiation were present in normal esophageal epithelium and the carcinoma was highly differentiated. Areas of glandular differentiation were discovered in normal gastric epithelium and the carcinoma was moderately differentiated. Therefore, we believe the two carcinomas arose independently.
Two histologically different tumors had collided without intermingling. Indeed, there was no intermingling of either the primary tumors or of metastases in the left cardial lymph node. Therefore, the pathology findings in this patient satisfy Dodge's criteria.
Collision tumors can be difficult to detect and diagnose [6] . Indeed, the disease in the present patient could not be diagnosed by upper gastrointestinal series or endoscopy. However, the presence of differing findings on pathology reports should raise clinicians' suspicions. If a preoperative diagnosis can be made, the patient's prognosis prognosis may be improved by the selection of preoperative radiotherapy or chemotherapy. Moreover, mediastinal and abdominal lymphadenectomy may be indicated in patients with esophageal and gastric double carcinomas. Clearly, clinicians need to be aware of the possibility of esophagogastric collision carcinoma. 
